These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12546929)

  • 1. Mistletoe lectins: telomerase inhibitors in alternative cancer therapy.
    Li SS
    Drug Discov Today; 2002 Sep; 7(17):896-7. PubMed ID: 12546929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating unconventional therapies.
    Hajto T; Saller R
    CMAJ; 1998 Oct; 159(7):759; author reply 759, 761. PubMed ID: 9805018
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of the recombinant A-chain of a type II ribosome-inactivating protein (RIP) from Viscum album coloratum and structural basis on its ribosome-inactivating activity and the sugar-binding properties of the B-chain.
    Ye W; Nanga RP; Kang CB; Song JH; Song SK; Yoon HS
    J Biochem Mol Biol; 2006 Sep; 39(5):560-70. PubMed ID: 17002877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin.
    Lyu SY; Kwon YJ; Joo HJ; Park WB
    Arch Pharm Res; 2004 Jan; 27(1):118-26. PubMed ID: 14969350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt.
    Choi SH; Lyu SY; Park WB
    Arch Pharm Res; 2004 Jan; 27(1):68-76. PubMed ID: 14969342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U; Göthel D; Leng-Peschlow E
    Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of different antigens of mistletoe extracts by anti-mistletoe lectin antibodies.
    Stein GM; Pfüller U; Berg PA
    Cancer Lett; 1999 Jan; 135(2):165-70. PubMed ID: 10096425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new gene encoding the ribosome-inactivating protein from mistletoe extracts.
    Tonevitsky AG; Agapov II; Pevzner IB; Maluchenko NV; Moisenovich MM; Palmer RA; Yurkova M; Pfüller K; Pfüller U
    Arzneimittelforschung; 2004; 54(4):242-9. PubMed ID: 15146937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of two Korean mistletoe lectins.
    Kang TB; Song SK; Yoon TJ; Yoo YC; Lee KH; Her E; Kim JB
    J Biochem Mol Biol; 2007 Nov; 40(6):959-65. PubMed ID: 18047792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
    Park JH; Hyun CK; Shin HK
    Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure at 3 A of mistletoe lectin I, a dimeric type-II ribosome-inactivating protein, complexed with galactose.
    Niwa H; Tonevitsky AG; Agapov II; Saward S; Pfüller U; Palmer RA
    Eur J Biochem; 2003 Jul; 270(13):2739-49. PubMed ID: 12823544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM; Stettin A; Schultze J; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins.
    Pryme IF; Bardocz S; Pusztai A; Ewen SW
    Histol Histopathol; 2006 Mar; 21(3):285-99. PubMed ID: 16372250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V
    J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
    Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
    Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53.
    Lyu SY; Choi SH; Park WB
    Arch Pharm Res; 2002 Feb; 25(1):93-101. PubMed ID: 11885700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of the genes encoding toxic lectins in mistletoe (Viscum album L).
    Kourmanova AG; Soudarkina OJ; Olsnes S; Kozlov JV
    Eur J Biochem; 2004 Jun; 271(12):2350-60. PubMed ID: 15182350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.